1. Home
  2. NAMS vs BKU Comparison

NAMS vs BKU Comparison

Compare NAMS & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • BKU
  • Stock Information
  • Founded
  • NAMS 2019
  • BKU 2009
  • Country
  • NAMS Netherlands
  • BKU United States
  • Employees
  • NAMS N/A
  • BKU N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • BKU Savings Institutions
  • Sector
  • NAMS Health Care
  • BKU Finance
  • Exchange
  • NAMS Nasdaq
  • BKU Nasdaq
  • Market Cap
  • NAMS 2.7B
  • BKU 2.8B
  • IPO Year
  • NAMS N/A
  • BKU 2011
  • Fundamental
  • Price
  • NAMS $25.71
  • BKU $39.19
  • Analyst Decision
  • NAMS Strong Buy
  • BKU Hold
  • Analyst Count
  • NAMS 10
  • BKU 11
  • Target Price
  • NAMS $41.40
  • BKU $41.82
  • AVG Volume (30 Days)
  • NAMS 982.1K
  • BKU 567.2K
  • Earning Date
  • NAMS 11-05-2025
  • BKU 10-21-2025
  • Dividend Yield
  • NAMS N/A
  • BKU 3.27%
  • EPS Growth
  • NAMS N/A
  • BKU 51.05
  • EPS
  • NAMS N/A
  • BKU 3.41
  • Revenue
  • NAMS $64,006,000.00
  • BKU $999,760,000.00
  • Revenue This Year
  • NAMS N/A
  • BKU $15.20
  • Revenue Next Year
  • NAMS $1.67
  • BKU $6.43
  • P/E Ratio
  • NAMS N/A
  • BKU $11.13
  • Revenue Growth
  • NAMS 762.15
  • BKU 13.39
  • 52 Week Low
  • NAMS $14.06
  • BKU $28.21
  • 52 Week High
  • NAMS $27.35
  • BKU $44.45
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 54.31
  • BKU 54.47
  • Support Level
  • NAMS $23.05
  • BKU $37.37
  • Resistance Level
  • NAMS $27.35
  • BKU $39.03
  • Average True Range (ATR)
  • NAMS 1.46
  • BKU 0.88
  • MACD
  • NAMS -0.18
  • BKU -0.12
  • Stochastic Oscillator
  • NAMS 57.79
  • BKU 57.23

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

Share on Social Networks: